Greig NH, Mattson MP, Perry T, Chan SL, Giordano T, Sambamurti K, Rogers JT, Ovadia H, Lahiri DK (2004) New therapeutic strategies and drug candidates for neurodegenerative diseases: p53 and TNF-alpha inhibitors, and GLP-1 receptor agonists
Long-term Safety Data Early studies show Retatrutide is safe, but we need more research
Thats notable because many women report that weight management becomes more challenging as hormone levels change, yet the weight-loss results were remarkably similar across groups
Activities that were difficult or impossible at the starting weight are now routine
Clinicians should monitor patients regularly and adjust expectations based on individual progress rather than population averages